Cargando…
CXCR5 CAR-T cells simultaneously target B cell non-Hodgkin’s lymphoma and tumor-supportive follicular T helper cells
CAR-T cell therapy targeting CD19 demonstrated strong activity against advanced B cell leukemia, however shows less efficacy against lymphoma with nodal dissemination. To target both B cell Non-Hodgkin’s lymphoma (B-NHLs) and follicular T helper (Tfh) cells in the tumor microenvironment (TME), we ap...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801647/ https://www.ncbi.nlm.nih.gov/pubmed/33431832 http://dx.doi.org/10.1038/s41467-020-20488-3 |
_version_ | 1783635619285565440 |
---|---|
author | Bunse, Mario Pfeilschifter, Janina Bluhm, Julia Zschummel, Maria Joedicke, Jara J. Wirges, Anthea Stark, Helen Kretschmer, Vivien Chmielewski, Markus Uckert, Wolfgang Abken, Hinrich Westermann, Jörg Rehm, Armin Höpken, Uta E. |
author_facet | Bunse, Mario Pfeilschifter, Janina Bluhm, Julia Zschummel, Maria Joedicke, Jara J. Wirges, Anthea Stark, Helen Kretschmer, Vivien Chmielewski, Markus Uckert, Wolfgang Abken, Hinrich Westermann, Jörg Rehm, Armin Höpken, Uta E. |
author_sort | Bunse, Mario |
collection | PubMed |
description | CAR-T cell therapy targeting CD19 demonstrated strong activity against advanced B cell leukemia, however shows less efficacy against lymphoma with nodal dissemination. To target both B cell Non-Hodgkin’s lymphoma (B-NHLs) and follicular T helper (Tfh) cells in the tumor microenvironment (TME), we apply here a chimeric antigen receptor (CAR) that recognizes human CXCR5 with high avidity. CXCR5, physiologically expressed on mature B and Tfh cells, is also highly expressed on nodal B-NHLs. Anti-CXCR5 CAR-T cells eradicate B-NHL cells and lymphoma-supportive Tfh cells more potently than CD19 CAR-T cells in vitro, and they efficiently inhibit lymphoma growth in a murine xenograft model. Administration of anti-murine CXCR5 CAR-T cells in syngeneic mice specifically depletes endogenous and malignant B and Tfh cells without unexpected on-target/off-tumor effects. Collectively, anti-CXCR5 CAR-T cells provide a promising treatment strategy for nodal B-NHLs through the simultaneous elimination of lymphoma B cells and Tfh cells of the tumor-supporting TME. |
format | Online Article Text |
id | pubmed-7801647 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-78016472021-01-21 CXCR5 CAR-T cells simultaneously target B cell non-Hodgkin’s lymphoma and tumor-supportive follicular T helper cells Bunse, Mario Pfeilschifter, Janina Bluhm, Julia Zschummel, Maria Joedicke, Jara J. Wirges, Anthea Stark, Helen Kretschmer, Vivien Chmielewski, Markus Uckert, Wolfgang Abken, Hinrich Westermann, Jörg Rehm, Armin Höpken, Uta E. Nat Commun Article CAR-T cell therapy targeting CD19 demonstrated strong activity against advanced B cell leukemia, however shows less efficacy against lymphoma with nodal dissemination. To target both B cell Non-Hodgkin’s lymphoma (B-NHLs) and follicular T helper (Tfh) cells in the tumor microenvironment (TME), we apply here a chimeric antigen receptor (CAR) that recognizes human CXCR5 with high avidity. CXCR5, physiologically expressed on mature B and Tfh cells, is also highly expressed on nodal B-NHLs. Anti-CXCR5 CAR-T cells eradicate B-NHL cells and lymphoma-supportive Tfh cells more potently than CD19 CAR-T cells in vitro, and they efficiently inhibit lymphoma growth in a murine xenograft model. Administration of anti-murine CXCR5 CAR-T cells in syngeneic mice specifically depletes endogenous and malignant B and Tfh cells without unexpected on-target/off-tumor effects. Collectively, anti-CXCR5 CAR-T cells provide a promising treatment strategy for nodal B-NHLs through the simultaneous elimination of lymphoma B cells and Tfh cells of the tumor-supporting TME. Nature Publishing Group UK 2021-01-11 /pmc/articles/PMC7801647/ /pubmed/33431832 http://dx.doi.org/10.1038/s41467-020-20488-3 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Bunse, Mario Pfeilschifter, Janina Bluhm, Julia Zschummel, Maria Joedicke, Jara J. Wirges, Anthea Stark, Helen Kretschmer, Vivien Chmielewski, Markus Uckert, Wolfgang Abken, Hinrich Westermann, Jörg Rehm, Armin Höpken, Uta E. CXCR5 CAR-T cells simultaneously target B cell non-Hodgkin’s lymphoma and tumor-supportive follicular T helper cells |
title | CXCR5 CAR-T cells simultaneously target B cell non-Hodgkin’s lymphoma and tumor-supportive follicular T helper cells |
title_full | CXCR5 CAR-T cells simultaneously target B cell non-Hodgkin’s lymphoma and tumor-supportive follicular T helper cells |
title_fullStr | CXCR5 CAR-T cells simultaneously target B cell non-Hodgkin’s lymphoma and tumor-supportive follicular T helper cells |
title_full_unstemmed | CXCR5 CAR-T cells simultaneously target B cell non-Hodgkin’s lymphoma and tumor-supportive follicular T helper cells |
title_short | CXCR5 CAR-T cells simultaneously target B cell non-Hodgkin’s lymphoma and tumor-supportive follicular T helper cells |
title_sort | cxcr5 car-t cells simultaneously target b cell non-hodgkin’s lymphoma and tumor-supportive follicular t helper cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801647/ https://www.ncbi.nlm.nih.gov/pubmed/33431832 http://dx.doi.org/10.1038/s41467-020-20488-3 |
work_keys_str_mv | AT bunsemario cxcr5cartcellssimultaneouslytargetbcellnonhodgkinslymphomaandtumorsupportivefollicularthelpercells AT pfeilschifterjanina cxcr5cartcellssimultaneouslytargetbcellnonhodgkinslymphomaandtumorsupportivefollicularthelpercells AT bluhmjulia cxcr5cartcellssimultaneouslytargetbcellnonhodgkinslymphomaandtumorsupportivefollicularthelpercells AT zschummelmaria cxcr5cartcellssimultaneouslytargetbcellnonhodgkinslymphomaandtumorsupportivefollicularthelpercells AT joedickejaraj cxcr5cartcellssimultaneouslytargetbcellnonhodgkinslymphomaandtumorsupportivefollicularthelpercells AT wirgesanthea cxcr5cartcellssimultaneouslytargetbcellnonhodgkinslymphomaandtumorsupportivefollicularthelpercells AT starkhelen cxcr5cartcellssimultaneouslytargetbcellnonhodgkinslymphomaandtumorsupportivefollicularthelpercells AT kretschmervivien cxcr5cartcellssimultaneouslytargetbcellnonhodgkinslymphomaandtumorsupportivefollicularthelpercells AT chmielewskimarkus cxcr5cartcellssimultaneouslytargetbcellnonhodgkinslymphomaandtumorsupportivefollicularthelpercells AT uckertwolfgang cxcr5cartcellssimultaneouslytargetbcellnonhodgkinslymphomaandtumorsupportivefollicularthelpercells AT abkenhinrich cxcr5cartcellssimultaneouslytargetbcellnonhodgkinslymphomaandtumorsupportivefollicularthelpercells AT westermannjorg cxcr5cartcellssimultaneouslytargetbcellnonhodgkinslymphomaandtumorsupportivefollicularthelpercells AT rehmarmin cxcr5cartcellssimultaneouslytargetbcellnonhodgkinslymphomaandtumorsupportivefollicularthelpercells AT hopkenutae cxcr5cartcellssimultaneouslytargetbcellnonhodgkinslymphomaandtumorsupportivefollicularthelpercells |